 |
市場調査レポート
商品コード
1532834
免疫療法薬市場：タイプ別、製品別、流通別、投与経路別、エンドユーザー別、国別、地域別-2024年～2032年の産業分析、市場規模、市場シェア、予測Immunotherapy Drugs Market, By Type, By Product, By Distribution, By Route of Administration, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
| 免疫療法薬市場：タイプ別、製品別、流通別、投与経路別、エンドユーザー別、国別、地域別-2024年～2032年の産業分析、市場規模、市場シェア、予測 |
|
出版日: 2024年07月30日
発行: AnalystView Market Insights
ページ情報: 英文 381 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
レポートハイライト
免疫療法薬の市場規模は2023年に2,788億9,778万米ドルとなり、2024年から2032年にかけてCAGR 14.92％で拡大
免疫療法薬市場-市場力学
世界のがん患者数の増加
がん罹患率の増加により、効果的な治療に対する需要が高まるがんと闘うために身体の免疫システムを利用する免疫療法は、一般的な選択肢となりつつあり、こうした薬剤の市場拡大につながっています。より効果的な新しい治療法の必要性は、研究開発（R&D）への投資に拍車をかけています。これには、臨床試験のための資金調達、新しい免疫療法アプローチの探求、新薬の開発などが含まれます。企業は、増大する需要に応えるため、製品ポートフォリオを拡大し、新たな市場に参入しています。これには、さまざまなタイプのがんに対する治療法の開発や、免疫療法の効果を高める併用療法の開発などが含まれます。例えば、ロンドンにあるがん研究所（The Institute of Cancer Research, London）の研究者たちは、新規で有効な可能性のあるがん治療薬を開発するために、低分子免疫腫瘍学ビジネスを展開するNeoPhore社と共同でネオアンチゲンの同定を行っています。クリス・ロード教授の指揮下にあるICRチームは、新たな戦略的研究協力の一環として、NeoPhore社の阻害剤が研究室で腫瘍にどのような影響を与えるかを調査します。
免疫療法薬市場-主な洞察
弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約14.92%のCAGRで毎年成長すると推定されます。
市場セグメンテーションでは、モノクローナル抗体が2023年に最大の市場シェアを示すと予測されています。
製品タイプ別では、2023年には生物製剤が主要タイプに
流通セグメント別では、2023年に小売薬局が主要タイプでした。
エンドユーザーセグメンテーションでは、2023年に病院が主要タイプでした。
地域別では、北米が2023年の売上高でトップ
免疫療法薬市場-セグメンテーション分析：
免疫療法薬の世界市場は、タイプ、製品、流通、投与経路、エンドユーザー、地域に基づいて区分されます。
製品はタイプ別に6つに分類される：モノクローナル抗体、ワクチン、チェックポイント阻害剤、非特異的免疫療法、がん細胞ウイルス免疫療法、T細胞療法です。 mAbsは、がん細胞、病原体、炎症細胞の表面にあるタンパク質など、特定の抗原に特異的に結合するように設計されています。この標的化によって、健康な細胞や組織へのダメージが最小限に抑えられ、治療がより効果的になり、副作用が軽減されます。また、治療に高い特異性をもたらすため、病気の正確な診断と治療に役立ちます。
市場は用途によって5つのカテゴリーに分けられる：すなわち、病院、診療所、がん研究センター、外来手術センター、在宅医療の現場です。免疫療法薬は、がん細胞を認識して破壊する身体の自然な免疫システムの能力を強化または回復させるように設計されています。この標的を絞ったアプローチは、化学療法や放射線療法のような従来の治療と比較して、より効果的で健康な細胞へのダメージが少ないです。免疫療法は、がん特有の特徴に基づいて個々の患者に合わせることができます。このような個別化アプローチにより、治療成績の向上と副作用の軽減が期待できます。
免疫療法薬市場-地理的洞察
免疫療法薬市場は、製薬業界において急成長している分野であり、北米の各地域で活発な活動と市場開拓が行われています。米国は、先進的なヘルスケアインフラ、充実した研究開発投資、高いがん罹患率を背景に、免疫療法市場の主要プレーヤーとなっています。FDAによる多数の免疫療法薬の承認、バイオテクノロジー企業や製薬企業の強力なプレゼンスが成長を後押ししています。ドイツ、フランス、英国などは、強力なヘルスケアシステムと活発な研究機関により、免疫療法市場で突出しています。欧州医薬品庁（EMA）は、医薬品の承認と市場参入において重要な役割を果たしています。さらにインドは、がん罹患率の増加やヘルスケアインフラの整備を背景に、免疫療法への関心が高まっている新興市場です。2023年10月、米国食品医薬品局（FDA）に相当するインドの中央医薬品標準管理機構（Central Drugs Standard Control Organization）は、NexCAR19をインド初のCAR-T細胞療法として承認しました。
免疫療法薬市場-競合情勢：
免疫療法薬市場における主要企業ブリストル・マイヤーズスクイブ、メルク社、ロシュ社、ファイザー社、ノバルティス社、アムジェン社など。免疫療法薬市場は多様性に富んでおり、モノクローナル抗体、チェックポイント阻害薬、CAR-T細胞療法、その他の革新的治療など、様々なセグメントに複数の主要企業が参入しています。メルク社はPD-1/PD-L1阻害剤のマーケットリーダーであり、豊富な臨床試験データと幅広い適応症を有しています。ファイザーは、免疫療法と標的治療の両方に精通し、強力な臨床研究を行っています。2024年2月、フロリダ大学ヘルスがんセンターの研究チームは、様々な種類のがんの治療に免疫療法を用いる新たな道を開く可能性のある、世界で初めての化合物を開発しました。さらに、カリフォルニア州サウザンドオークスとニュージャージー州ケニルワースは、非ホジキンリンパ腫（NHL）の中で最も多いタイプのびまん性大細胞型B細胞リンパ腫（DLBCL）患者を対象に、BLINCYTOとKEYTRUDAの併用療法を検討するフェーズ1b/3試験を支援するがん免疫療法共同研究を発表しました。この市場は急速な技術革新が特徴で、併用療法や個別化治療など、より効果的な新しい治療法の開拓に重点が置かれています。
目次
第1章 免疫療法薬市場概要
- 調査範囲
- 市場推定年
第2章 エグゼクティブサマリー
- 市場内訳
- 競合考察
第3章 免疫療法薬の主要市場動向
- 市場促進要因
- 市場抑制要因
- 市場機会
- 市場の将来動向
第4章 免疫療法薬産業の調査
- PEST分析
- ポーターのファイブフォース分析
- 成長見通しマッピング
- 規制枠組み分析
第5章 免疫療法薬市場： COVID-19の影響分析
- COVID-19以前の影響分析
- COVID-19後の影響分析
第6章 免疫療法薬市場情勢
- 免疫療法薬市場シェア分析、2023年
- 主要メーカー別内訳データ
- 既存企業の分析
- 新興企業の分析
第7章 免疫療法薬市場- タイプ別
- 概要
- セグメントシェア分析（タイプ別）
- モノクローナル抗体
- ワクチン
- チェックポイント阻害剤
- 非特異的免疫療法
- 腫瘍溶解性ウイルス免疫療法
- T細胞療法
第8章 免疫療法薬市場- 製品別
- 概要
- 製品別セグメントシェア分析
- 生物学的製剤
- 組み換えタンパク質
- 抗体
- 小分子
第9章 免疫療法薬市場- 流通別
- 概要
- セグメントシェア分析（流通別）
- 病院薬局
- 小売薬局
- オンライン薬局
第10章 免疫療法薬市場- 投与経路別
- 概要
- 製品別セグメントシェア分析
- 静脈（IV）
- 皮下
- 経口
- 筋肉
第11章 免疫療法薬市場- エンドユーザー別
- 概要
- エンドユーザー別セグメントシェア分析
- 病院
- クリニック
- がん研究センター
- 外来手術センター
- ホームケア設定
第12章 免疫療法薬市場-地域別
- イントロダクション
- 北米
- 概要
- 北米の主要メーカー
- 米国
- カナダ
- 欧州
- 概要
- 欧州の主要メーカー
- ドイツ
- イタリア
- 英国
- フランス
- ロシア
- オランダ
- スウェーデン
- ポーランド
- その他
- アジア太平洋（APAC）
- 概要
- アジア太平洋の主要メーカー
- インド
- 中国
- 日本
- 韓国
- オーストラリア
- タイ
- インドネシア
- フィリピン
- その他
- ラテンアメリカ
- 概要
- ラテンアメリカの主要メーカー
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他
- 中東・アフリカ
- 概要
- 中東・アフリカの主要メーカー
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- トルコ
- アルジェリア
- エジプト
- その他
第13章 主要ベンダー分析- 免疫療法薬業界
- 競合ダッシュボード
- 企業プロファイル
- Bristol-Myers Squibb
- Merck &Co.
- Roche
- Pfizer
- Novartis
- Gilead Sciences
- Amgen
- Sanofi
- Regeneron Pharmaceuticals
- Bluebird Bio
- Cellectis
- Others
第14章 アナリストの全方位展望
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Immunotherapy Drugs Market: Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Immunotherapy Drugs Market, by Type 2019-2032 (USD Million)
- TABLE Immunotherapy Drugs Market: Product Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Product
- TABLE Global Immunotherapy Drugs Market, by Product 2019-2032 (USD Million)
- TABLE Immunotherapy Drugs Market: Distribution Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Distribution
- TABLE Global Immunotherapy Drugs Market, by Distribution 2019-2032 (USD Million)
- TABLE Immunotherapy Drugs Market: Route of Administration Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Route of Administration
- TABLE Global Immunotherapy Drugs Market, by Route of Administration 2019-2032 (USD Million)
- TABLE Immunotherapy Drugs Market: End User Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End User
- TABLE Global Immunotherapy Drugs Market, by End User 2019-2032 (USD Million)
- TABLE Immunotherapy Drugs Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Immunotherapy Drugs Market, by Region 2019-2032 (USD Million)
- TABLE North America Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
- TABLE North America Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
- TABLE North America Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
- TABLE North America Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
- TABLE North America Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
- TABLE North America Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
- TABLE Europe Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
- TABLE Europe Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
- TABLE Europe Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
- TABLE Europe Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
- TABLE Europe Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
- TABLE Latin America Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
- TABLE Latin America Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
- TABLE Latin America Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
- TABLE Latin America Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
- TABLE Latin America Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
List of Figures
- FIGURE Immunotherapy Drugs Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2023
- FIGURE Type segment market share analysis, 2023 & 2032
- FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Product segment market share analysis, 2023 & 2032
- FIGURE Product segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Distribution segment market share analysis, 2023 & 2032
- FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Route of Administration segment market share analysis, 2023 & 2032
- FIGURE Route of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE End User segment market share analysis, 2023 & 2032
- FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Regional segment market share analysis, 2023 & 2032
- FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE North America Immunotherapy Drugs Market share and leading players, 2023
- FIGURE Europe Immunotherapy Drugs Market share and leading players, 2023
- FIGURE Asia Pacific Immunotherapy Drugs Market share and leading players, 2023
- FIGURE Latin America Immunotherapy Drugs Market share and leading players, 2023
- FIGURE Middle East and Africa Immunotherapy Drugs Market share and leading players, 2023
- FIGURE North America market share analysis by country, 2023
- FIGURE U.S. Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Canada Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Europe Immunotherapy Drugs Market share analysis by country, 2023
- FIGURE Germany Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Spain Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Italy Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE France Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE UK Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Russia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Netherlands Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Sweden Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Poland Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of the Europe Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Asia Pacific Immunotherapy Drugs Market share analysis by country, 2023
- FIGURE India Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE China Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Japan Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE South Korea Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Australia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Thailand Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Indonesia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Philippines Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of APAC Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Immunotherapy Drugs Market share analysis by country, 2023
- FIGURE Brazil Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Mexico Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Argentina Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Colombia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of LATAM Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Immunotherapy Drugs Market share analysis by country, 2023
- FIGURE Saudi Arabia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE United Arab Emirates Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Israel Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Turkey Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Algeria Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Egypt Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of MEA Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
REPORT HIGHLIGHT
Immunotherapy Drugs Market size was valued at USD 278,897.78 million in 2023, expanding at a CAGR of 14.92% from 2024 to 2032.
The rising number of cancer cases worldwide is a major driver for the growth of immunotherapy drugs. Immunotherapies offer new hope for patients with various types of cancer. Continuous R&D in immunotherapy has led to the development of more effective and targeted therapies, including checkpoint inhibitors, CAR-T cell therapies, and monoclonal antibodies. However, some immunotherapies can cause severe side effects, such as cytokine release syndrome or autoimmune reactions, which need careful management. The production of some immunotherapy drugs, like CAR-T cell therapies, involves complex and costly manufacturing processes. Furthermore, strategic collaborations between pharmaceutical companies, research institutions, and biotech firms can accelerate the development of new therapies and expand market reach.
Immunotherapy Drugs Market- Market Dynamics
The increasing number of cancer cases worldwide
The growing incidence of cancer drives demand for effective treatments. Immunotherapy, which harnesses the body's immune system to fight cancer, is becoming a popular choice, leading to an increased market for these drugs. The need for new and more effective treatments spurs investment in research and development (R&D). This includes funding for clinical trials, exploring new immunotherapy approaches, and developing novel drugs. Companies are expanding their product portfolios and entering new markets to meet the growing demand. This includes developing therapies for different types of cancer and creating combination treatments that enhance the effectiveness of immunotherapies. For instance, To create novel, potentially effective cancer medications, researchers at The Institute of Cancer Research, London, are collaborating with NeoPhore, a small molecule immuno-oncology business, to identify neoantigens. An ICR team under the direction of Professor Chris Lord will examine how NeoPhore's inhibitors affect tumors in the lab as part of a new strategic research cooperation.
Immunotherapy Drugs Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.92% over the forecast period (2024-2032)
Based on type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023
Based on product segmentation, Biologics was the leading type in 2023
Based on distribution segmentation, Retail Pharmacies was the leading type in 2023
Based on end-user segmentation, Hospitals was the leading type in 2023
based on region, North America was the leading revenue generator in 2023
Immunotherapy Drugs Market- Segmentation Analysis:
The Global Immunotherapy Drugs Market is segmented based on Type, Product, Distribution, Route of Administration, End User, and Region.
The market is divided into six categories based on product type: Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Non-Specific Immunotherapies, Oncolytic Virus Immunotherapy, and T-Cell Therapy. mAbs are designed to bind specifically to certain antigens, such as proteins on the surface of cancer cells, pathogens, or inflammatory cells. This targeting minimizes damage to healthy cells and tissues, making treatments more effective and reducing side effects. They provide high specificity in treatment, which helps in accurately diagnosing and treating diseases.
The market is divided into five categories based on application: Hospitals, Clinics, Cancer Research Centers, Ambulatory Surgical Centers, and Homecare Settings. Immunotherapy drugs are designed to enhance or restore the body's natural immune system's ability to recognize and destroy cancer cells. This targeted approach can be more effective and less damaging to healthy cells compared to traditional treatments like chemotherapy and radiation. Immunotherapy can be tailored to individual patients based on the specific characteristics of their cancer. This personalized approach can improve treatment outcomes and reduce side effects.
Immunotherapy Drugs Market- Geographical Insights
The immunotherapy drugs market is a rapidly growing sector in the pharmaceutical industry, with significant activity and development occurring across North American regions. The U.S. is a major player in the immunotherapy market due to its advanced healthcare infrastructure, substantial R&D investments, and high prevalence of cancer. The FDA's approval of numerous immunotherapy drugs and the strong presence of biotech and pharmaceutical companies drive growth. Countries like Germany, France, and the UK are prominent in the immunotherapy market due to their strong healthcare systems and active research institutions. The European Medicines Agency (EMA) plays a crucial role in drug approvals and market access. Furthermore, India is an emerging market with growing interest in immunotherapy, driven by increasing cancer incidence and improving healthcare infrastructure. In October 2023, India's counterpart to the US Food and Drug Administration, the Central Drugs Standard Control Organization, made NexCAR19 India's first approved CAR-T cell therapy.
Immunotherapy Drugs Market- Competitive Landscape:
Leading players in the immunotherapy drugs market Bristol-Myers Squibb, Merck & Co., Roche, Pfizer, Novartis, and Amgen, etc. The immunotherapy drugs market is diverse and includes several key players across various segments, including monoclonal antibodies, checkpoint inhibitors, CAR-T cell therapies, and other innovative treatments. Merck & Co. is a market leader in PD-1/PD-L1 inhibitors, with extensive clinical trial data, and broad indications. Pfizer has expertise in both immunotherapy and targeted therapies and strong clinical research. In February 2024, A team of UF Health Cancer Center researchers developed a first-of-its-kind compound that could open a new avenue for using immunotherapy to treat various types of cancer. In addition, THOUSAND OAKS, Calif. and KENILWORTH, N.J., announced a cancer immunotherapy collaboration to support a Phase 1b/3 study investigating BLINCYTO in combination with KEYTRUDA in patients with diffuse large B-cell lymphoma (DLBCL), which is the most common type of non-Hodgkin lymphoma (NHL). The market is characterized by rapid innovation, with a focus on developing new and more effective therapies, including combination therapies and personalized treatments.
Recent Developments:
In April 2024, BostonGene and Saga University announced the launch of a collaboration aimed at discovering biomarkers for immunotherapy (IO) treatment response and treatment-related toxicity in advanced non-small cell lung cancer (NSCLC) patients. EGFR-TKI treatment effectively targets EGFR mutation-positive NSCLC. Still, acquired resistance often leads to recurrence within 1 to 2 years, presenting a challenge for post-treatment optimization.
In June 2022, The Mark Foundation for Cancer Research expanded its partnership with the Johns Hopkins University to accelerate groundbreaking immunotherapy research. The collaboration with the Bloomberg~Kimmel Institute allows us to develop the next-generation genomics and imaging platforms for cancer immunotherapy necessary to save lives.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOTHERAPY DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Bristol-Myers Squibb
Merck & Co.
Roche
Pfizer
Novartis
Gilead Sciences
Amgen
Sanofi
Regeneron Pharmaceuticals
Bluebird Bio
Cellectis
Others
GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Monoclonal Antibodies
- Vaccines
- Checkpoint Inhibitors
- Non-Specific Immunotherapies
- Oncolytic Virus Immunotherapy
- T-Cell Therapy
GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032
- Biologics
- Recombinant Proteins
- Antibodies
- Small Molecules
GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
- Intravenous (IV)
- Subcutaneous
- Oral
- Intramuscular
GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Clinics
- Cancer Research Centers
- Ambulatory Surgical Centers
- Homecare Settings
GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Immunotherapy Drugs Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Immunotherapy Drugs Market Snippet by Type
- 2.1.2. Immunotherapy Drugs Market Snippet by Product
- 2.1.3. Immunotherapy Drugs Market Snippet by Distribution
- 2.1.4. Immunotherapy Drugs Market Snippet by Route of Administration
- 2.1.5. Immunotherapy Drugs Market Snippet by End User
- 2.1.6. Immunotherapy Drugs Market Snippet by Country
- 2.1.7. Immunotherapy Drugs Market Snippet by Region
- 2.2. Competitive Insights
3. Immunotherapy Drugs Key Market Trends
- 3.1. Immunotherapy Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Immunotherapy Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Immunotherapy Drugs Market Opportunities
- 3.4. Immunotherapy Drugs Market Future Trends
4. Immunotherapy Drugs Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Immunotherapy Drugs Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Immunotherapy Drugs Market Landscape
- 6.1. Immunotherapy Drugs Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Immunotherapy Drugs Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Monoclonal Antibodies
- 7.1.3. Vaccines
- 7.1.4. Checkpoint Inhibitors
- 7.1.5. Non-Specific Immunotherapies
- 7.1.6. Oncolytic Virus Immunotherapy
- 7.1.7. T-Cell Therapy
8. Immunotherapy Drugs Market - By Product
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
- 8.1.2. Biologics
- 8.1.2.1. Recombinant Proteins
- 8.1.2.2. Antibodies
- 8.1.3. Small Molecules
9. Immunotherapy Drugs Market - By Distribution
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
- 9.1.2. Hospital Pharmacies
- 9.1.3. Retail Pharmacies
- 9.1.4. Online Pharmacies
10. Immunotherapy Drugs Market - By Route of Administration
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
- 10.1.2. Intravenous (IV)
- 10.1.3. Subcutaneous
- 10.1.4. Oral
- 10.1.5. Intramuscular
11. Immunotherapy Drugs Market - By End User
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 11.1.2. Hospitals
- 11.1.3. Clinics
- 11.1.4. Cancer Research Centers
- 11.1.5. Ambulatory Surgical Centers
- 11.1.6. Homecare Settings
12. Immunotherapy Drugs Market- By Geography
- 12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 12.2. North America
- 12.2.1. Overview
- 12.2.2. Immunotherapy Drugs Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
- 12.2.9.1. Overview
- 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.2.9.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.2.9.4. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.2.9.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
- 12.2.10.1. Overview
- 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.2.10.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.2.10.4. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.2.10.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3. Europe
- 12.3.1. Overview
- 12.3.2. Immunotherapy Drugs Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
- 12.3.9.1. Overview
- 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.9.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.9.4. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.9.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
- 12.3.10.1. Overview
- 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.10.4. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.10.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
- 12.3.11.1. Overview
- 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.11.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.11.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.11.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. France
- 12.3.12.1. Overview
- 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.12.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.12.4. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.12.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
- 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.13.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.13.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.13.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
- 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.14.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.14.3. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.14.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
- 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.15.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.15.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.15.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
- 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.16.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.16.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
- 12.3.17.1. Overview
- 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.17.4. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Immunotherapy Drugs Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. India
- 12.4.9.1. Overview
- 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.9.4. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.9.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. China
- 12.4.10.1. Overview
- 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.10.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.10.4. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.10.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
- 12.4.11.1. Overview
- 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.11.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.11.4. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.11.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
- 12.4.12.1. Overview
- 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.12.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.12.4. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.12.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
- 12.4.13.1. Overview
- 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.13.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.13.4. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.13.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
- 12.4.14.1. Overview
- 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.14.4. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.14.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
- 12.4.15.1. Overview
- 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.15.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.15.4. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.15.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
- 12.4.16.1. Overview
- 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.16.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.16.4. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.16.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
- 12.4.17.1. Overview
- 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.17.4. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Immunotherapy Drugs Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
- 12.5.9.1. Overview
- 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.9.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.9.4. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.5.9.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
- 12.5.10.1. Overview
- 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.10.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.10.4. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.5.10.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
- 12.5.11.1. Overview
- 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.11.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.11.4. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.5.11.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
- 12.5.12.1. Overview
- 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.12.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.12.4. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.5.12.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
- 12.5.13.1. Overview
- 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.13.4. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Immunotherapy Drugs Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
- 12.6.9.1. Overview
- 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.9.4. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
- 12.6.10.1. Overview
- 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.10.4. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
- 12.6.11.1. Overview
- 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.11.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.11.4. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.11.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
- 12.6.12.1. Overview
- 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.12.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.12.4. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.12.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
- 12.6.13.1. Overview
- 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.13.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.13.4. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.13.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
- 12.6.14.1. Overview
- 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.14.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.14.4. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.14.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
- 12.6.15.1. Overview
- 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.15.4. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Immunotherapy Drugs Industry
- 13.1. Competitive Dashboard
- 13.2. Company Profiles
- 13.2.1. Bristol-Myers Squibb
- 13.2.2. Merck & Co.
- 13.2.3. Roche
- 13.2.4. Pfizer
- 13.2.5. Novartis
- 13.2.6. Gilead Sciences
- 13.2.7. Amgen
- 13.2.8. Sanofi
- 13.2.9. Regeneron Pharmaceuticals
- 13.2.10. Bluebird Bio
- 13.2.11. Cellectis
- 13.2.12. Others
14. 360 Degree Analyst View
15. Appendix
- 15.1. Research Methodology
- 15.2. References
- 15.3. Abbreviations
- 15.4. Disclaimer
- 15.5. Contact Us
